Brian Kelly
Roche (United States)(US)Ventana Research Corporation (United States)(US)
Publications by Year
Research Areas
Asymmetric Hydrogenation and Catalysis, Asymmetric Synthesis and Catalysis, Chemical Synthesis and Analysis, Cancer, Hypoxia, and Metabolism, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1(2004)1,148 cited
- Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.(2003)
- → Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1(2003)604 cited
- → Germline mutations in the ribonuclease L gene in families showing linkage with HPC1(2002)525 cited
- Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.(2003)
- → OS-9 Interacts with Hypoxia-Inducible Factor 1α and Prolyl Hydroxylases to Promote Oxygen-Dependent Degradation of HIF-1α(2005)221 cited
- → Linkage and Association Studies of Prostate Cancer Susceptibility: Evidence for Linkage at 8p22-23(2001)155 cited